EUVIMEDEUVIMED entdecken
Crossref

Integrating network pharmacology, molecular docking, and bioinformatics to explore the mechanism of sparganii rhizoma in the treatment of laryngeal cancer

Meiling Zheng, Rui Zhang, Xinxing Yang, Feiyan Wang, Xiaodi Guo, Long Li, Jin Wang, Yajun Shi, Shan Miao, Wei Quan, Shanbo Ma, Xiaopeng Shi

Molecular Diversity · 2025

DOI: 10.1007/s11030-025-11142-5 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Diversity, 2025. Verfasst von Meiling Zheng und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Shaanxi University of Chinese Medicine, Xianyang, Shaanxi, People's Republic of China. Hauptthemen laut MEDLINE: Molecular Docking Simulation, Network Pharmacology, Laryngeal Neoplasms, Drugs, Chinese Herbal. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 68 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Sparganii Rhizoma (SR) has demonstrated promising anticancer effects across various malignancies; however, its mechanisms in laryngeal cancer (LC) remain poorly understood. This study employs network pharmacology and molecular docking to investigate the molecular mechanisms underlying SR's therapeutic effects on LC, providing novel insights for its potential use in treatment. Active compounds and targets of SR were identified through the TCMSP and Pharmmapper databases, while LC-related targets were sourced from GEO, GeneCards, OMIM, and PharmGkb databases. A Venn diagram generated from these datasets highlighted 58 overlapping targets. The STRING database and Cytoscape 3.9.1 software facilitated the construction of a protein-protein interaction network for these targets, and R language analysis revealed 15 core targets. GO and KEGG enrichment analyses, conducted with the ''clusterProfiler'' package, identified relevant biological processes, cellular components, and molecular functions associated with LC treatment. KEGG analysis suggested SR primarily regulates pathways such as TNF, IL-17, and P53. Molecular docking confirmed SR's ability to bind effectively to the 15 core targets. Molecular dynamics simulations further validated stable protein-ligand interactions for MAPK1, GSK3B, and MAPK14. Core target validation across transcriptional, translational, and immune infiltration levels was performed using GEPIA, HPA, cBioPortal, and TIMER databases. In conclusion, network pharmacology, molecular docking, and dynamics simulations provided insights into SR's mechanism in LC treatment, forming a theoretical basis for further investigation of its therapeutic potential.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Molecular Docking SimulationNetwork PharmacologyLaryngeal NeoplasmsDrugs, Chinese HerbalComputational BiologyRhizomeHumansProtein Interaction MapsMolecular Dynamics Simulation

Stichwörter der Autor:innen

GEO datasetsLaryngeal cancerMolecular dockingMolecular dynamics simulationsNetwork pharmacologySparganii rhizoma

Substanzen

Drugs, Chinese Herbal

Autor:innen und Institutionen

  • Department of Pharmacy, Shaanxi University of Chinese Medicine, Xianyang, Shaanxi, People's Republic of China.
  • Department of Pharmacy, Xijing Hospital, The Fourth Military Medical University, Xi'an, Shaanxi, People's Republic of China.
  • Department of Otolaryngology-Head and Neck Surgery, Xijing Hospital, The Fourth Military Medical University, Xi'an, Shaanxi, People's Republic of China.
  • Ultrasound Department of The First Affiliated Hospital of The Fourth Military Medical University, Xi'an, Shaanxi, People's Republic of China.
  • The College of Life Sciences, Northwest University, Xi'an, Shaanxi, People's Republic of China.
  • Department of Pharmacy, Affiliated Hospital of Shaanxi University of Chinese Medicine, Xianyang, Shaanxi, China. fmmuquanwei@163.com.

Zitieren

APA

Zheng, M., Zhang, R., Yang, X., Wang, F., Guo, X., Li, L., Wang, J., Shi, Y., Miao, S., Quan, W., Ma, S., & Shi, X. (2025). Integrating network pharmacology, molecular docking, and bioinformatics to explore the mechanism of sparganii rhizoma in the treatment of laryngeal cancer. Molecular Diversity. https://doi.org/10.1007/s11030-025-11142-5

Vancouver

Zheng M, Zhang R, Yang X, Wang F, Guo X, Li L, et al. Integrating network pharmacology, molecular docking, and bioinformatics to explore the mechanism of sparganii rhizoma in the treatment of laryngeal cancer. Molecular Diversity. 2025. doi:10.1007/s11030-025-11142-5

BibTeX
@article{Zheng2025,
  author = {Zheng, Meiling and Zhang, Rui and Yang, Xinxing and Wang, Feiyan and Guo, Xiaodi and Li, Long and Wang, Jin and Shi, Yajun and Miao, Shan and Quan, Wei and Ma, Shanbo and Shi, Xiaopeng},
  title = {Integrating network pharmacology, molecular docking, and bioinformatics to explore the mechanism of sparganii rhizoma in the treatment of laryngeal cancer},
  journal = {Molecular Diversity},
  year = {2025},
  doi = {10.1007/s11030-025-11142-5}
}
Kostenlos starten →